Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/01/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT |
|
2 | |
| 03/29/11 | 8-K | Current report filing |
|
4 | |
| 03/28/11 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/18/11 | 8-K | Current report filing |
|
4 | |
| 02/10/11 | DEF 14A | Definitive proxy statements |
|
10 | |
| 02/02/11 | UPLOAD | SEC-generated letter |
|
2 | |
| 01/24/11 | PRE 14A | Preliminary proxy statement not related to a contested matter or merger/acquisition |
|
11 | |
| 01/24/11 | CORRESP | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. |
|
2 | |
| 01/06/11 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
56 |
